KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Realty Trust (HR) Shares Outstanding (Diluted Average) (2016 - 2026)

Healthcare Realty Trust has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $347.4 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 0.6% year-over-year to $347.4 million; the TTM value through Mar 2026 reached $347.4 million, down 0.6%, while the annual FY2025 figure was $349.8 million, 4.31% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $347.4 million at Healthcare Realty Trust, down from $349.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $379.5 million in Q1 2024 and troughed at $149.1 million in Q1 2022.
  • A 5-year average of $323.6 million and a median of $349.8 million in 2025 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 32.94% in 2022 and later skyrocketed 154.17% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $253.9 million in 2022, then soared by 49.26% to $378.9 million in 2023, then fell by 3.53% to $365.6 million in 2024, then dropped by 4.31% to $349.8 million in 2025, then dropped by 0.67% to $347.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HR at $347.4 million in Q1 2026, $349.8 million in Q4 2025, and $349.7 million in Q3 2025.